0775:HKG
CK Life Sciences Intl (Holdings) Inc
0,51 HK$
arrow_downward
-1,92%(-0,0100) 1D
15. 10., 10:55:09 GMT+8 · HKD
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro 0775…
Otevřít
0,52 HK$
Max.
0,52 HK$
Min.
0,51 HK$
Trž. kap.
4,90 mld.
Prům. obj.
1,64 mil.
Objem
316,00 tis.
52týd. max.
1,02 HK$
52týd. min.
0,51 HK$
EPS
-0,01 HK$
Akcie v oběhu
9,61 mld.
Počet zaměstnanců
2 tis.
Otevřít
0,52 HK$
Max.
0,52 HK$
Min.
0,51 HK$
Trž. kap.
4,90 mld.
Prům. obj.
1,64 mil.
Objem
316,00 tis.
52týd. max.
1,02 HK$
52týd. min.
0,51 HK$
EPS
-0,01 HK$
Akcie v oběhu
9,61 mld.
Počet zaměstnanců
2 tis.
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
The Daily News | Texas' Oldest Newspaper
·
před 44 minutami
FILE PHOTO: SK Hynix at the Nasdaq market in New York
Simply Wall Street
·
před 13 minutami
Raised Guidance Could Change The Case For Nextpower Stock
Yardeni QuickTakes
·
před 20 minutami
Continue To Proceed With Caution
Yahoo Finance
·
před 6 hodinami
You’d Be Foolish to Ignore 5% Returns on Bonds, Especially as Blue-Chip Stocks Fail to Deliver
Profil
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
Informace o CK Life Sciences Intl (Holdings) Inc